Published in Cell on October 01, 1980
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol (1987) 3.65
Bacterial toxins: cellular mechanisms of action. Microbiol Rev (1984) 3.42
Membrane receptors for bacterial toxins. Microbiol Rev (1983) 2.41
Mutant Chinese hamster ovary cells pleiotropically defective in receptor-mediated endocytosis. J Cell Biol (1983) 2.17
Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells. Infect Immun (1991) 2.12
Mechanism of entry into the cytosol of poliovirus type 1: requirement for low pH. J Cell Biol (1984) 2.05
Routing of internalized ricin and ricin conjugates to the Golgi complex. J Cell Biol (1986) 1.90
Morphologic study of the internalization of a lysosomal enzyme by the mannose 6-phosphate receptor in cultured Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1981) 1.81
C. elegans detects pathogen-induced translational inhibition to activate immune signaling. Cell Host Microbe (2012) 1.79
Receptor-mediated endocytosis of diphtheria toxin by cells in culture. Proc Natl Acad Sci U S A (1982) 1.59
Effect of methylamine and monodansylcadaverine on the susceptibility of McCoy cells to Chlamydia trachomatis infection. Infect Immun (1983) 1.57
Effects of chloroquine and cytochalasin B on the infection of cells by Sindbis virus and vesicular stomatitis virus. J Virol (1981) 1.51
Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugate. J Virol (1984) 1.44
Strains of CHO-K1 cells resistant to Pseudomonas exotoxin A and cross-resistant to diphtheria toxin and viruses. Infect Immun (1983) 1.41
Requirements for entry of poliovirus RNA into cells at low pH. EMBO J (1984) 1.41
Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun (1985) 1.36
Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein. J Cell Biol (1995) 1.29
Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism. Infect Immun (1995) 1.16
A Chinese hamster ovary cell mutant with a heat-sensitive, conditional-lethal defect in vacuolar function. J Cell Biol (1984) 1.16
Receptor-mediated entry of Pseudomonas toxin: methylamine blocks clustering step. Infect Immun (1983) 1.15
Staphylococcal toxic shock toxin specifically binds to cultured human epithelial cells and is rapidly internalized. Infect Immun (1984) 1.13
Enhancement of toxicity of antitransferrin receptor antibody-Pseudomonas exotoxin conjugates by adenovirus. Proc Natl Acad Sci U S A (1983) 1.09
Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1. Am J Pathol (1986) 1.04
Inhibition of endoplasmic reticulum-associated degradation in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and ricin. Infect Immun (2002) 1.04
Pertussis toxin-catalyzed ADP-ribosylation of Gi-2 and Gi-3 in CHO cells is modulated by inhibitors of intracellular trafficking. Infect Immun (1996) 1.03
Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa. Biochem J (2005) 1.01
Reduced temperature alters Pseudomonas exotoxin A entry into the mouse LM cell. Infect Immun (1986) 1.00
The Murid Herpesvirus-4 gL regulates an entry-associated conformation change in gH. PLoS One (2008) 0.99
Analysis of Pseudomonas exotoxin activation and conformational changes by using monoclonal antibodies as probes. Infect Immun (1991) 0.97
Evidence for pseudomonas exotoxin A receptors on plasma membrane of toxin-sensitive lm fibroblasts. Infect Immun (1984) 0.97
Toxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives. Infect Immun (1984) 0.94
Essential role of calcium in cellular internalization of Pseudomonas toxin. Infect Immun (1982) 0.91
Diphtheria toxin does not enter resistant cells by receptor-mediated endocytosis. Infect Immun (1983) 0.90
Level of receptor-associated protein moderates cellular susceptibility to pseudomonas exotoxin A. Infect Immun (1995) 0.83
Lymphoproliferative activity of Pseudomonas exotoxin A is dependent on intracellular processing and is associated with the carboxyl-terminal portion. Infect Immun (1992) 0.83
The effects of chloroquine and other weak bases on the accumulation and efflux of digoxin and ouabain in HeLa cells. Br J Pharmacol (1983) 0.80
Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein. Infect Immun (2001) 0.80
Recovery of function in Chinese hamster ovary cell mutants with temperature-sensitive defects in vacuolar acidification. J Cell Biol (1990) 0.79
Mouse liver contains a Pseudomonas aeruginosa exotoxin A-binding protein. Infect Immun (1991) 0.79
Elevation of vacuolar pH inhibits the cytotoxic activity of furin-cleaved exotoxin A. Infect Immun (1997) 0.78
Characterization of monoclonal antibody B7, which neutralizes the cytotoxicity of Pseudomonas aeruginosa exotoxin A. Clin Diagn Lab Immunol (1996) 0.78
A re-evaluation of the role of histidine-426 within Pseudomonas aeruginosa exotoxin A. Biochem J (2002) 0.77
Host detection of pathogen-induced translational inhibition: a new pathogen-specific branch of the innate immune system? Future Microbiol (2012) 0.75
Shigella infection of henle intestinal epithelial cells: role of the host cell. Infect Immun (1979) 5.09
Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa. Infect Immun (1978) 3.15
The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem (1992) 2.40
Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A (1996) 2.29
Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc Natl Acad Sci U S A (1990) 2.12
Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues. J Infect Dis (1977) 1.84
The epidemiology of serious eye injuries from the United States Eye Injury Registry. Graefes Arch Clin Exp Ophthalmol (2000) 1.81
Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain. J Biol Chem (1988) 1.73
Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol (1999) 1.72
Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. J Biol Chem (1991) 1.61
Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. Ther Drug Monit (2001) 1.53
Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells. Circulation (1991) 1.51
Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. Lancet (1991) 1.49
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer. Br J Cancer (2002) 1.45
Newer immunosuppressive drugs: a review. J Am Soc Nephrol (1999) 1.43
Chemical modulation of diphtheria toxin action on cultured mammalian cells. Infect Immun (1975) 1.37
The transforming growth factor-betas. A new family of immunoregulatory molecules. Ann N Y Acad Sci (1990) 1.36
Recombinant toxins for cancer treatment. Science (1991) 1.36
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol (2001) 1.36
Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun (1985) 1.36
Interaction of cultured mammalian cells with [125I] diphtheria toxin. Infect Immun (1975) 1.34
Evolving techniques in the treatment of macular detachment caused by optic nerve pits. Ophthalmology (1988) 1.32
AnkB, a periplasmic ankyrin-like protein in Pseudomonas aeruginosa, is required for optimal catalase B (KatB) activity and resistance to hydrogen peroxide. J Bacteriol (2000) 1.31
Domain II mutants of Pseudomonas exotoxin deficient in translocation. J Biol Chem (1989) 1.31
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide. Curr Opin Immunol (1996) 1.31
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. Circulation (1999) 1.30
Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein. J Cell Biol (1995) 1.29
Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med (1990) 1.28
Role of domain II of Pseudomonas exotoxin in the secretion of proteins into the periplasm and medium by Escherichia coli. Proc Natl Acad Sci U S A (1988) 1.27
Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli. Proc Natl Acad Sci U S A (1988) 1.24
Pseudomonas exotoxin: chimeric toxins. J Biol Chem (1989) 1.23
Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation (1993) 1.22
Furin-mediated cleavage of Pseudomonas exotoxin-derived chimeric toxins. J Biol Chem (1997) 1.21
Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells. J Biol Chem (1990) 1.21
Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity. J Mol Biol (2001) 1.18
Globe perforation from peribulbar injection. Arch Ophthalmol (1987) 1.17
Receptor-mediated entry of Pseudomonas toxin: methylamine blocks clustering step. Infect Immun (1983) 1.15
SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families. Am J Med Genet B Neuropsychiatr Genet (2008) 1.12
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg (1996) 1.10
Efficacy of treatment modalities in refractive amblyopia. J Am Optom Assoc (1999) 1.08
Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum. J Immunol (1999) 1.07
Localization of ClC-2 Cl- channels in rabbit gastric mucosa. Am J Physiol Cell Physiol (2001) 1.06
The role of respiratory epithelium in a rat model of obliterative airway disease. Transplantation (2000) 1.06
Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD. Transplant Proc (2001) 1.06
Vitrectomy in asteroid hyalosis. Retina (1990) 1.05
Inhibition of protein synthesis after intravenous or intramuscular challenge with diphtheria toxin. Infect Immun (1972) 1.05
Dental caries experience of disabled children and young adults in Kuwait. Community Dent Health (2001) 1.04
Characterization of a cellular protease that cleaves Pseudomonas exotoxin. Infect Immun (1992) 1.01
Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01
The N-terminal region of the 37-kDa translocated fragment of Pseudomonas exotoxin A aborts translocation by promoting its own export after microsomal membrane insertion. Proc Natl Acad Sci U S A (1993) 1.00
Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J Immunol (2001) 1.00
Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells. J Histochem Cytochem (1989) 1.00
Technics for fiberoptic laryngoscopy in anesthesia. Anesth Analg (1974) 1.00
Reduced temperature alters Pseudomonas exotoxin A entry into the mouse LM cell. Infect Immun (1986) 1.00
Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line. Biochim Biophys Acta (1988) 0.99
Association of down-regulation of cytokine activity with rat hind limb allograft survival. Transplantation (1995) 0.97
Analysis of Pseudomonas exotoxin activation and conformational changes by using monoclonal antibodies as probes. Infect Immun (1991) 0.97
Evidence for pseudomonas exotoxin A receptors on plasma membrane of toxin-sensitive lm fibroblasts. Infect Immun (1984) 0.97
Isolation and characterization of Pseudomonas aeruginosa exotoxin A binding glycoprotein from mouse LM cells. J Biol Chem (1991) 0.96
Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Am J Respir Cell Mol Biol (1999) 0.96
Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin. Cancer Res (1991) 0.96
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation (1995) 0.96
Immunosuppressants: cellular and molecular mechanisms of action. Am J Kidney Dis (1996) 0.94
PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol Anim (2000) 0.93
Interaction of pseudomonas exoproducts with phagocytic cells. Can J Microbiol (1982) 0.93
A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing. J Biol Chem (1992) 0.92
Ocular self-mutilation. Ann Ophthalmol (1989) 0.92
Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats. Proc Natl Acad Sci U S A (1989) 0.92
Visualization of intracellular trafficking: use of biotinylated ligands in conjunction with avidin-gold colloids. J Histochem Cytochem (1984) 0.92
Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients. Transplantation (2000) 0.92
Essential role of calcium in cellular internalization of Pseudomonas toxin. Infect Immun (1982) 0.91
Mutagenesis of Pseudomonas exotoxin in identification of sequences responsible for the animal toxicity. J Biol Chem (1990) 0.91
Immortalization of subpopulations of respiratory epithelial cells from transgenic mice bearing SV40 large T antigen. Am J Physiol (1994) 0.90
Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice. J Clin Invest (1992) 0.90
Diphtheria toxin does not enter resistant cells by receptor-mediated endocytosis. Infect Immun (1983) 0.90
Pseudomonas exotoxin A mutants. Replacement of surface-exposed residues in domain III with cysteine residues that can be modified with polyethylene glycol in a site-specific manner. J Biol Chem (1994) 0.90
Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates. Cancer Res (1987) 0.90
Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro. J Immunol Methods (2001) 0.90
A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2. Transplant Proc (1996) 0.90
Informed consent in emergency medicine: ethics under fire. Emerg Med Clin North Am (1996) 0.89
Studies on the effect of diphtheria toxin on protein synthesis in mice. J Med Microbiol (1973) 0.89
Leflunomide and malononitriloamides. Expert Opin Investig Drugs (1997) 0.89
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. Transplant Proc (1993) 0.89
Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts. Eur J Cardiothorac Surg (2001) 0.88
Vascular endothelial growth factor in the rat pituitary: differential distribution and regulation by estrogen. J Endocrinol (2000) 0.88
Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. J Pharmacol Exp Ther (1999) 0.88
Ethical considerations. Crit Care Clin (1993) 0.88
Pirfenidone: A novel anti-fibrotic agent and progressive chronic allograft rejection. Pulm Pharmacol Ther (2002) 0.87
Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats. Transplantation (2000) 0.87
IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptors. J Immunol (1988) 0.87
Use of nondepolarizing anesthetic agents in penetrating ocular injuries. Anesthesiology (1986) 0.86